Several European countries have suspended the inoculation of the AstraZeneca vaccine out of suspicion that it causes deep vein thrombosis. In this letter, we report some Fermi estimates performed using a stochastic model aimed at making a risk-benefit analysis of the interruption of the delivery of the AstraZeneca vaccine in France and Italy. Our results clearly show that excess deaths due to the interruption of the vaccination campaign injections largely overrun those due to thrombosis even in worst case scenarios of frequency and gravity of the vaccine side effects.
Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: The AstraZeneca case for France and Italy
Lembo, ValerioMembro del Collaboration Group
;
2021
Abstract
Several European countries have suspended the inoculation of the AstraZeneca vaccine out of suspicion that it causes deep vein thrombosis. In this letter, we report some Fermi estimates performed using a stochastic model aimed at making a risk-benefit analysis of the interruption of the delivery of the AstraZeneca vaccine in France and Italy. Our results clearly show that excess deaths due to the interruption of the vaccination campaign injections largely overrun those due to thrombosis even in worst case scenarios of frequency and gravity of the vaccine side effects.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
2103.14904.pdf
solo utenti autorizzati
Tipologia:
Documento in Pre-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
2.3 MB
Formato
Adobe PDF
|
2.3 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
041105_1_online.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
1.53 MB
Formato
Adobe PDF
|
1.53 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Accepted_Lembo_2103.14904.pdf
accesso aperto
Descrizione: Published under an exclusive license by AIP Publishing. http://dx.doi.org/10.1063/5.0050887
Tipologia:
Documento in Post-print
Licenza:
Altro tipo di licenza
Dimensione
2.3 MB
Formato
Adobe PDF
|
2.3 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.